For decades, the process of drug discovery has been a prolonged, costly, and unpredictable endeavor — an effort that ...
MedPage Today on MSN
Five Leaders in One Year: FDA's Drug Center Enters 2026 at a Crossroads
The FDA appointed George Tidmarsh, MD, PhD, to be the nation's top drug official in July. The Center for Drug Evaluation and ...
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
Scientists are literally turning back the clocks in our cells, with the first drugs about to go to human trials ...
The Opinion columnist M. Gessen examines how the president governs through spectacle, and the message his displays of force ...
2don MSNOpinion
Chemistry is stuck in the dark ages: 'Chemputation' can bring it into the digital world
Chemistry deals with that most fundamental subject: matter. New drugs, materials and batteries all depend on our ability to ...
The DMTA cycle depends on clear data flow, yet most labs still work across disconnected systems. Sean McGee, Director of ...
In coming weeks, Wegovy pill will be available in four doses: a starter dose of 1.5 mg, as well as 4 mg, 9 mg, and 25 mg. As ...
Learn about Agentic AI and its role in enhancing decision-making in drug discovery through planned actions and verified ...
News-Medical.Net on MSN
Scientists capture real-time action of antiviral drugs on herpes
Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.
As Dry January fuels interest in hemp-infused drinks, new U.S. legislation could soon ban intoxicating hemp products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results